en

PRODUCT DETAIL

Flucloxacillin Fresenius Kabi 2 g

Code 5842D
MA number 15/0239/20-S
Product Form: plo ijf 10x2 g (liek.inj.skl.)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
MAH, country: Fresenius Kabi s.r.o., Czechia
Therapeutic Class: 15 - ANTIBIOTICA (PROTI MIKROB. A VÍRUSOVÝM INFEKCIAM)
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS
J01CF Beta-lactamase resistant penicillins
J01CF05 Flucloxacillin
Shelf life: 24
Container: glass vial
Route of admin.: Intramuscular or intravenous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 27.11.2020
Pediatric posology: Yes
Pediatric warnings: Yes
PIL: PIL_Flucloxacillin Fresenius Kabi 1 g a 2 g plo ijf_05.2023.pdf  
SPC: SPC_Flucloxacillin Fresenius Kabi 1 g a 2 g plo ijf_05.2023.pdf  
Safety feature Yes
Data update: 31.01.2025
eu-flag.png sk-flag.png